Clinical Trial Update: Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy [Phase 3]

View source ↗

Summary

A Phase 3 trial investigated whether adding trastuzumab to radiation therapy improves outcomes for women with ductal carcinoma in situ after lumpectomy; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ of the Breast

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Ductal Carcinoma In Situ | Phase 3 | Status: COMPLETED | Results posted: 2022-02-23